• head_banner_01

Renewable Design for 3-Nitrophthalic Acid - Semaglutide for Type 2 Diabetes – Gentolex

Short Description:


Product Detail

Product Tags

Related Video

Feedback (2)

We take "customer-friendly, quality-oriented, integrative, innovative" as objectives. "Truth and honesty" is our management ideal for Mirabegron, Low Sodium Potassium And Chloride, Eptifibatide, The mission of our firm should be to provide the best high quality goods with finest price tag. We've been on the lookout forward to doing organization with you!
Renewable Design for 3-Nitrophthalic Acid - Semaglutide for Type 2 Diabetes – Gentolex Detail:

Product Detail

Name  Semaglutide
CAS number  910463-68-2
Molecular formula  C187H291N45O59
Molecular weight  4113.57754
EINECS Number  203-405-2

Synonyms

Sermaglutide; Semaglutide fandachem; Semaglutide impurity; Sermaglutide USP/EP; semaglutide; Sermaglutide CAS 910463 68 2; Ozempic, 

Description

Semaglutide is a new generation of GLP-1 (glucagon-like peptide-1) analogs, and semaglutide is a long-acting dosage form developed based on the basic structure of liraglutide, which has a better effect in the treatment of type 2 diabetes. Novo Nordisk has completed 6 Phase IIIa studies of semaglutide injection, and submitted a new drug registration application for semaglutide weekly injection to the U.S. Food and Drug Administration (FDA) on December 5, 2016. A Marketing Authorization Application (MAA) was also submitted to the European Medicines Agency (EMA).

Compared with liraglutide, semaglutide has a longer aliphatic chain and increased hydrophobicity, but semaglutide is modified with a short chain of PEG, and its hydrophilicity is greatly enhanced. After PEG modification, it can not only bind closely to albumin, cover the enzymatic hydrolysis site of DPP-4, but also reduce renal excretion, prolong the biological half-life, and achieve the effect of long circulation.

Application

Semaglutide is a long-acting dosage form developed based on the basic structure of liraglutide, which is more effective in treating type 2 diabetes.

Bioactivity

Semaglutide (Rybelsus, Ozempic, NN9535, OG217SC, NNC0113-0217) is a long-acting glucagon-like peptide 1 (GLP-1) analog, an agonist of GLP-1receptor, with a potential type 2 Therapeutic efficacy of diabetes mellitus (T2DM).

Quality System

In general, quality system and assurance is in place covering all stage of production of the finished product. Adequate manufacturing and control operations are performed in compliance with the approved procedures/ specifications. Change control and Deviation handling system is in place, and necessary impact assessment and investigation were conducted. Proper procedures are in place to ensure quality of product prior to release into the market.


Product detail pictures:

Renewable Design for 3-Nitrophthalic Acid - Semaglutide for Type 2 Diabetes – Gentolex detail pictures

Renewable Design for 3-Nitrophthalic Acid - Semaglutide for Type 2 Diabetes – Gentolex detail pictures


Related Product Guide:

Our advantages are lower prices,dynamic sales team,specialized QC,strong factories,high quality products and services for Renewable Design for 3-Nitrophthalic Acid - Semaglutide for Type 2 Diabetes – Gentolex , The product will supply to all over the world, such as: US, Philippines, Indonesia, Our factory is equipped with complete facility in 10000 square meters, which makes us be able to satisfy the producing and sales for most auto part solutions. Our advantage is full category, high quality and competitive price! Based on that, our products win a high admiration both at home and abroad.
  • Products and services are very good, our leader is very satisfied with this procurement, it is better than we expected,
    5 Stars By Josephine from Australia - 2018.09.29 17:23
    Goods just received, we are very satisfied, a very good supplier, hope to make persistent efforts to do better.
    5 Stars By Rita from Rotterdam - 2018.12.22 12:52
    Write your message here and send it to us